Weihua Zhai
Overview
Explore the profile of Weihua Zhai including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
58
Citations
223
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhen S, Liu L, Zhang X, Wang J, Sun J, Liang C, et al.
Bone Marrow Transplant
. 2025 Mar;
PMID: 40033131
No abstract available.
2.
Cao J, Zheng Y, Li R, Feng D, Ni X, Gao H, et al.
Am J Hematol
. 2025 Feb;
PMID: 39950584
No abstract available.
3.
Wang M, Chen S, Zhang Q, Yuan L, Wang X, Zhang J, et al.
Front Immunol
. 2025 Jan;
15():1511057.
PMID: 39845970
Introduction: Hematopoietic stem cell transplantation (HSCT) and chemotherapy are considered potentially curative options for post-remission therapy in acute myeloid leukemia (AML). However, the comparative effectiveness of these approaches in favorable-...
4.
Feng D, Liu Q, Gao H, Cao Y, Chen X, Zhang R, et al.
Br J Haematol
. 2024 Dec;
206(2):769-772.
PMID: 39676311
No abstract available.
5.
Chen S, Zhang X, Niu T, Xu Y, Gao G, Fan S, et al.
Am J Cancer Res
. 2024 Nov;
14(10):4969-4978.
PMID: 39553212
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) maintains the only promising curative option for patients with refractory/relapsed (R/R) acute myeloid leukemia (AML). However, the long-term survival results are suboptimal. Optimization of...
6.
Li L, Chen Y, Chen T, Xu Y, Zhu P, Shi J, et al.
Bone Marrow Transplant
. 2024 Nov;
60(2):201-210.
PMID: 39516707
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) utilizing mismatched unrelated donors (MMUD) present a vital option for patients with hematologic malignancies without human leukocyte antigen (HLA)-matched donors. This multicenter retrospective study...
7.
Li J, Ma R, Wang H, Wang Y, Pang A, Yang D, et al.
Br J Haematol
. 2024 Oct;
206(2):753-757.
PMID: 39434482
No abstract available.
8.
Zhang Y, Wang Y, Ma R, Liu L, Sun J, Chen X, et al.
Front Immunol
. 2024 Oct;
15:1437176.
PMID: 39386205
Introduction: Currently, no study has determined whether platelet transfusion refractoriness (PTR) post-hematopoietic stem cell transplantation (HSCT) before engraftment in patients with myelodysplastic syndrome (MDS) would impacts clinical outcomes. Methods: We...
9.
Zhang H, Guo W, Wang J, Lu N, Zheng X, Sun Q, et al.
Bone Marrow Transplant
. 2024 Aug;
59(12):1654-1666.
PMID: 39192082
Bone marrow fibrosis (BMF) of unknown etiology was common in hematological malignancies, but its prognostic value for acute myeloid leukemia (AML) is unclear. We interrogated data from 532 newly diagnosed...
10.
Gao H, Zhang Z, Wang J, Jia Y, Zheng Y, Pei X, et al.
Exp Hematol Oncol
. 2024 Aug;
13(1):88.
PMID: 39182130
The optimal timing and type of hematopoietic stem cell transplantation (HSCT) for treating peripheral T-cell lymphoma (PTCL) remain controversial. This retrospective real-world study investigated the application pattern and outcomes of...